These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9303415)

  • 41. Group C streptococcal meningitis: case report and review of the literature.
    Shah SS; Matthews RP; Cohen C
    Pediatr Infect Dis J; 2001 Apr; 20(4):445-8. PubMed ID: 11332674
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibiotic concentrations in liquor compared to the minimal inhibitory concentrations of isolates in paediatric bacterial meningitis. The Finnish Study Group.
    Ellmén JK; Renkonen OV; Anttila MA; Peltola HO
    Chemotherapy; 1991; 37(1):1-5. PubMed ID: 1901543
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of gram-negative bacterial meningitis in term neonates with third generation cephalosporins plus amikacin.
    Dellagrammaticas HD; Christodoulou C; Megaloyanni E; Papadimitriou M; Kapetanakis J; Kourakis G
    Biol Neonate; 2000 Mar; 77(3):139-46. PubMed ID: 10729716
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of gatifloxacin alone and in combination with cefepime against penicillin-resistant Streptococcus pneumoniae in a rabbit meningitis model and in vitro.
    Perrig M; Acosta F; Cottagnoud M; Gerber CM; Täuber MG; Cottagnoud P
    J Antimicrob Chemother; 2001 May; 47(5):701-4. PubMed ID: 11328789
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Concentrations of cefpirome in cerebrospinal fluid of children with bacterial meningitis after a single intravenous dose.
    Friedland IR; Sultan E; Lehr KH; Lenfant B
    Antimicrob Agents Chemother; 1998 Jan; 42(1):199-201. PubMed ID: 9449289
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Breakthrough bacteremia and meningitis during treatment with cephalosporins parenterally for pneumococcal pneumonia.
    Buckingham SC; Brown SP; Joaquin VH
    J Pediatr; 1998 Jan; 132(1):174-6. PubMed ID: 9470026
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combating drug-resistant pneumococcal infections.
    Sanford JB
    Hosp Pract (Off Ed); 1994 Oct; 29(10):31-6; discussion 36-7. PubMed ID: 7929673
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cefotaxime therapy of bacterial meningitis in children.
    Wells TG; Trang JM; Brown AL; Marmer BC; Jacobs RF
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():181-9. PubMed ID: 6094438
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cefepime cerebrospinal fluid concentrations in neonatal bacterial meningitis.
    Ellis JM; Rivera L; Reyes G; Castillo F; Marte P; Tejada M; Salazar JC
    Ann Pharmacother; 2007 May; 41(5):900-1. PubMed ID: 17426074
    [No Abstract]   [Full Text] [Related]  

  • 50. Empirical treatment of adult postsurgical nosocomial meningitis.
    De Bels D; Korinek AM; Bismuth R; Trystram D; Coriat P; Puybasset L
    Acta Neurochir (Wien); 2002 Oct; 144(10):989-95. PubMed ID: 12382127
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Simultaneous determination of cefepime and vancomycin in plasma and cerebrospinal fluid by MEKC with direct sample injection and application for bacterial meningitis.
    Yang YH; Wu WY; Yeh HH; Chen SH
    Electrophoresis; 2007 Jun; 28(11):1788-97. PubMed ID: 17465423
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Failure of treatment of pneumonia associated with highly resistant pneumococci in a child.
    Dowell SF; Smith T; Leversedge K; Snitzer J
    Clin Infect Dis; 1999 Aug; 29(2):462-3. PubMed ID: 10476773
    [No Abstract]   [Full Text] [Related]  

  • 53. Post-operative meningitis caused by drug-resistant Streptococcus pneumoniae: two case reports.
    Pancharoen C; Pongpunlert W; Likitnukul S; Thisyakorn U
    Scand J Infect Dis; 2004; 36(5):380-1. PubMed ID: 15287384
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment recommendations for invasive pneumococcal infections updated; resistance is behind change.
    Am J Health Syst Pharm; 1997 Apr; 54(7):747-8. PubMed ID: 9099338
    [No Abstract]   [Full Text] [Related]  

  • 55. Experimental study of the efficacy of vancomycin, rifampicin and dexamethasone in the therapy of pneumococcal meningitis.
    Martínez-Lacasa J; Cabellos C; Martos A; Fernández A; Tubau F; Viladrich PF; Liñares J; Gudiol F
    J Antimicrob Chemother; 2002 Mar; 49(3):507-13. PubMed ID: 11864951
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vancomycin use.
    Rosenberg NM; Zeigler T; Warden C; Shane SA; Burton LJ
    Pediatr Emerg Care; 1999 Feb; 15(1):74-7. PubMed ID: 10069321
    [No Abstract]   [Full Text] [Related]  

  • 57. Invasive pneumococcal disease in Indian adults: 11 years' experience.
    Jayaraman R; Varghese R; Kumar JL; Neeravi A; Shanmugasundaram D; Ralph R; Thomas K; Veeraraghavan B
    J Microbiol Immunol Infect; 2019 Oct; 52(5):736-742. PubMed ID: 29884448
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapy of penicillin-resistant pneumococcal meningitis.
    Schwartz MT; Tunkel AR
    Zentralbl Bakteriol; 1995 Jan; 282(1):7-12. PubMed ID: 7734832
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Meningitis due to ceftriaxone-resistant Streptococcus pneumoniae.
    Lonks JR; Durkin MR; Meyerhoff AN; Medeiros AA
    N Engl J Med; 1995 Mar; 332(13):893-4. PubMed ID: 7870156
    [No Abstract]   [Full Text] [Related]  

  • 60. Evaluation of combined ceftriaxone and dexamethasone therapy in experimental cephalosporin-resistant pneumococcal meningitis.
    Cabellos C; Martínez-Lacasa J; Tubau F; Fernández A; Viladrich PF; Liñares J; Gudiol F
    J Antimicrob Chemother; 2000 Mar; 45(3):315-20. PubMed ID: 10702550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.